SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Emmaus Life Sciences, Inc. – ‘10-K’ for 9/30/14 – ‘R30’

On:  Monday, 12/29/14, at 5:19pm ET   ·   For:  9/30/14   ·   Accession #:  1144204-14-76185   ·   File #:  1-35527

Previous ‘10-K’:  ‘10-K/A’ on 1/28/14 for 9/30/13   ·   Next:  ‘10-K/A’ on 1/23/15 for 9/30/14   ·   Latest:  ‘10-K’ on 3/31/23 for 12/31/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/29/14  Emmaus Life Sciences, Inc.        10-K        9/30/14   70:12M                                    Toppan Merrill/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    750K 
 2: EX-4.4      Instrument Defining the Rights of Security Holders  HTML     37K 
 3: EX-10.89    Material Contract                                   HTML     61K 
 4: EX-10.90    Material Contract                                   HTML     34K 
 5: EX-10.91    Material Contract                                   HTML    107K 
 6: EX-23.1     Consent of Experts or Counsel                       HTML     20K 
 7: EX-31.1     Certification -- §302 - SOA'02                      HTML     25K 
 8: EX-31.2     Certification -- §302 - SOA'02                      HTML     25K 
 9: EX-32.1     Certification -- §906 - SOA'02                      HTML     21K 
10: EX-32.2     Certification -- §906 - SOA'02                      HTML     21K 
49: R1          Document And Entity Information                     HTML     51K 
39: R2          Consolidated Balance Sheets                         HTML    121K 
47: R3          Consolidated Balance Sheets [Parenthetical]         HTML     47K 
51: R4          Consolidated Statements of Operations               HTML    102K 
65: R5          Consolidated Statements of Changes in               HTML    117K 
                Stockholders' Deficit                                            
41: R6          Consolidated Statements of Cash Flows               HTML    140K 
46: R7          Nature of Operations                                HTML     36K 
36: R8          Summary of Significant Accounting Policies          HTML     98K 
27: R9          Discontinued Operations                             HTML     56K 
66: R10         Convertible Debt and Equity Financings              HTML     84K 
53: R11         Derivative Liabilities                              HTML     43K 
52: R12         Stockholders' Deficit                               HTML    335K 
57: R13         Income Taxes                                        HTML     62K 
58: R14         Related Party Transactions                          HTML     86K 
56: R15         Loss Per Share                                      HTML     54K 
59: R16         Commitments and Contingent Liabilities              HTML     61K 
48: R17         Significant Customers                               HTML     26K 
50: R18         Summary of Significant Accounting Policies          HTML    162K 
                (Policies)                                                       
55: R19         Summary of Significant Accounting Policies          HTML     48K 
                (Tables)                                                         
70: R20         Discontinued Operations (Tables)                    HTML     51K 
61: R21         Convertible Debt and Equity Financings (Tables)     HTML     51K 
43: R22         Derivative Liabilities (Tables)                     HTML     38K 
54: R23         Stockholders' Deficit (Tables)                      HTML    300K 
45: R24         Income Taxes (Tables)                               HTML     59K 
22: R25         Loss Per Share (Tables)                             HTML     50K 
62: R26         Commitments and Contingent Liabilities (Tables)     HTML     41K 
67: R27         Nature of Operations (Details Textual)              HTML     47K 
31: R28         Summary of Significant Accounting Policies          HTML     34K 
                (Details)                                                        
30: R29         Summary of Significant Accounting Policies          HTML     44K 
                (Details 1)                                                      
34: R30         Summary of Significant Accounting Policies          HTML    105K 
                (Details Textual)                                                
35: R31         Discontinued Operations (Details)                   HTML     65K 
37: R32         Convertible Debt and Equity Financings (Details)    HTML     59K 
21: R33         Convertible Debt and Equity Financings (Details     HTML    197K 
                Textual)                                                         
60: R34         Derivative Liabilities (Details)                    HTML     35K 
42: R35         Derivative Liabilities (Details Textual)            HTML     56K 
44: R36         Stockholders' Deficit (Details)                     HTML    109K 
25: R37         Stockholders' Deficit (Details 1)                   HTML     44K 
69: R38         Stockholders' Deficit (Details 2)                   HTML     39K 
17: R39         Stockholders' Deficit (Details 3)                   HTML     52K 
38: R40         Stockholders' Deficit (Details 4)                   HTML    181K 
64: R41         Stockholders' Deficit (Details 5)                   HTML     81K 
24: R42         Stockholders' Deficit (Details Textual)             HTML    529K 
29: R43         Income Taxes (Details)                              HTML     49K 
33: R44         Income Taxes (Details1)                             HTML     47K 
40: R45         Income Taxes (Details Textual)                      HTML     28K 
20: R46         Related Party Transactions (Details Textual)        HTML    546K 
26: R47         Loss Per Share (Details)                            HTML     57K 
18: R48         Commitments and Contingent Liabilities (Details)    HTML     61K 
63: R49         Commitments and Contingent Liabilities (Details     HTML     83K 
                Textual)                                                         
23: R50         Significant Customers (Details Textual)             HTML     24K 
68: XML         IDEA XML File -- Filing Summary                      XML     95K 
19: EXCEL       IDEA Workbook of Financial Reports                  XLSX    215K 
28: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   2.17M 
11: EX-101.INS  XBRL Instance -- cnso-20140930                       XML   2.73M 
13: EX-101.CAL  XBRL Calculations -- cnso-20140930_cal               XML    142K 
14: EX-101.DEF  XBRL Definitions -- cnso-20140930_def                XML   1.23M 
15: EX-101.LAB  XBRL Labels -- cnso-20140930_lab                     XML   1.45M 
16: EX-101.PRE  XBRL Presentations -- cnso-20140930_pre              XML   1.35M 
12: EX-101.SCH  XBRL Schema -- cnso-20140930                         XSD    274K 
32: ZIP         XBRL Zipped Folder -- 0001144204-14-076185-xbrl      Zip    225K 


‘R30’   —   Summary of Significant Accounting Policies (Details Textual)


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v2.4.1.9
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Textual) (USD $)
4 Months Ended 12 Months Ended 2 Months Ended 3 Months Ended
Significant Accounting Policies [Line Items]          
Property, Plant and Equipment, Depreciation Methods   straight-line basis      
Depreciation   $ 10,300us-gaap_Depreciation $ 13,000us-gaap_Depreciation    
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment   75,000us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment 64,800us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment    
Debt Instrument, Convertible, Conversion Price (in dollars per share) $ 1us-gaap_DebtInstrumentConvertibleConversionPrice1        
Accounts Payable, Trade   501,600us-gaap_AccountsPayableTradeCurrentAndNoncurrent      
Stock Issued During Period, Value, Issued For Services     7,900us-gaap_StockIssuedDuringPeriodValueIssuedForServices    
Advertising Expense   3,100us-gaap_AdvertisingExpense 14,400us-gaap_AdvertisingExpense    
Cash, FDIC Insured Amount   250,000us-gaap_CashFDICInsuredAmount      
Cash, Uninsured Amount   990,600us-gaap_CashUninsuredAmount      
Derivative Liability, Current   153,100us-gaap_DerivativeLiabilitiesCurrent 0us-gaap_DerivativeLiabilitiesCurrent    
Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net   26,100us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet 0us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet    
Stock Traded, Value 277,636cnso_StockTradedValue        
Debt Instrument, Convertible, Terms of Conversion Feature   As the original conversion terms of the notes were at $1 into one share of common stock with a fair value of $0.25, consequently, the three additional shares offered on conversion at $0.25 each represent the inducement to convert.      
Allowance for Doubtful Accounts Receivable   1,200us-gaap_AllowanceForDoubtfulAccountsReceivable 5,900us-gaap_AllowanceForDoubtfulAccountsReceivable    
Accounts Payable, Write-backs   44,000cnso_AccountsPayableWritebacks      
Deferred Revenue   45,900us-gaap_DeferredRevenue 0us-gaap_DeferredRevenue    
Debt Instrument Conversion Vote Percentage 100.00%cnso_DebtInstrumentConversionVotePercentage 100.00%cnso_DebtInstrumentConversionVotePercentage      
Two Creditors [Member]          
Significant Accounting Policies [Line Items]          
Stock Issued During Period, Shares, Issued For Services (in shares)       1,446,380us-gaap_StockIssuedDuringPeriodSharesIssuedForServices
/ us-gaap_TitleOfIndividualAxis
= cnso_TwoCreditorsMember
 
Stock Issued During Period, Value, Issued For Services       1,466,800us-gaap_StockIssuedDuringPeriodValueIssuedForServices
/ us-gaap_TitleOfIndividualAxis
= cnso_TwoCreditorsMember
 
Extinguishment of Debt, Gain (Loss), Net of Tax       1,105,200us-gaap_ExtinguishmentOfDebtGainLossNetOfTax
/ us-gaap_TitleOfIndividualAxis
= cnso_TwoCreditorsMember
 
Share Price       $ 0.25us-gaap_SharePrice
/ us-gaap_TitleOfIndividualAxis
= cnso_TwoCreditorsMember
 
Accredited Third Party Investor [Member]          
Significant Accounting Policies [Line Items]          
Stock Issued During Period, Share Price $ 0.25us-gaap_SharesIssuedPricePerShare
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= cnso_AccreditedThirdPartyInvestorMember
       
Proceeds From Issuance Of Private Placement 827,500us-gaap_ProceedsFromIssuanceOfPrivatePlacement
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= cnso_AccreditedThirdPartyInvestorMember
  2,000,000us-gaap_ProceedsFromIssuanceOfPrivatePlacement
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= cnso_AccreditedThirdPartyInvestorMember
   
Private Placement [Member]          
Significant Accounting Policies [Line Items]          
Proceeds From Issuance Of Private Placement         2,500,000us-gaap_ProceedsFromIssuanceOfPrivatePlacement
/ us-gaap_SubsidiarySaleOfStockAxis
= us-gaap_PrivatePlacementMember
Private Placement [Member] | Accredited Third Party Investor [Member]          
Significant Accounting Policies [Line Items]          
Proceeds From Issuance Of Private Placement         $ 695,000us-gaap_ProceedsFromIssuanceOfPrivatePlacement
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= cnso_AccreditedThirdPartyInvestorMember
/ us-gaap_SubsidiarySaleOfStockAxis
= us-gaap_PrivatePlacementMember
Minimum [Member]          
Significant Accounting Policies [Line Items]          
Property, Plant and Equipment, Useful Life   3 years      
Stock Traded, Price $ 0.41cnso_StockTradedPrice
/ us-gaap_RangeAxis
= us-gaap_MinimumMember
       
Maximum [Member]          
Significant Accounting Policies [Line Items]          
Property, Plant and Equipment, Useful Life   5 years      
Stock Traded, Price $ 2.50cnso_StockTradedPrice
/ us-gaap_RangeAxis
= us-gaap_MaximumMember
       

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:12/29/14
For Period end:9/30/1410-K/A,  D
12/31/1310-Q
9/30/1310-K,  10-K/A,  ARS
8/12/134,  4/A,  8-K
3/26/138-K
 List all Filings 
Top
Filing Submission 0001144204-14-076185   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 12:07:28.1am ET